reference/19931844

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19931844

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	242
issn	0002-9149
issueIdentifier	3
pageRange	236-242
publicationName	The American Journal of Cardiology
startingPage	236
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b39c7c69988f00ac2afdaa527e571807
bibliographicCitation	Catella-Lawson F, Kapoor S, Moretti D, De Marco S, Vigilante GJ, Cucchiara AJ, Ramsey KE, Combe S, Rocca B, Theroux P, FitzGerald GA; AFIRME Investigators. Antagonism of the Fibrinogen Receptor after Myocardial Events. Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease. Am J Cardiol. 2001 Aug 01;88(3):236–42. doi: 10.1016/s0002-9149(01)01632-0. PMID: 11472700.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_896228c55fe536efaaed5ae1a4008ee6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_552cf89368b17fb896f3fd0f2f13c17e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c7822cc60c8656c1fbbb26488fd362d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fcbc2b0136d172c2e87e2ac63c24126a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6f55b50478c839a9674268c2afe0c0d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0499e8773aabd7abf5d0b3bbe91e00f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1321a443484278efd64e78bc20c6ef28 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_355dacddf04bb26c245bcfbaa6c2d131 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2daeac24c19c44a7f4c53b26258098ae http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d7a09ecc24fccb8ffff31805b8a41e4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ffa717097f5f075a6f63d893a106796
date	2001-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/11472700 https://doi.org/10.1016/s0002-9149%2801%2901632-0
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/408 https://portal.issn.org/resource/ISSN/0002-9149
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0016238 http://id.nlm.nih.gov/mesh/M0028424 http://id.nlm.nih.gov/mesh/M0017012 http://id.nlm.nih.gov/mesh/M0021439
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001241Q000008 http://id.nlm.nih.gov/mesh/D010455Q000493 http://id.nlm.nih.gov/mesh/D003327Q000188 http://id.nlm.nih.gov/mesh/D010455Q000008 http://id.nlm.nih.gov/mesh/D010974Q000187 http://id.nlm.nih.gov/mesh/D010975Q000008 http://id.nlm.nih.gov/mesh/D019039Q000037
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D001241Q000009 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D013929Q000097 http://id.nlm.nih.gov/mesh/D003327Q000097 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D010975Q000009 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D013921Q000139 http://id.nlm.nih.gov/mesh/D010455Q000009 http://id.nlm.nih.gov/mesh/D004305
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7347 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7346 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9806811 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_050c9d8444b3439eaff87a40031b7008 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9408 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7065

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205760

Total number of triples: 66.